Drugs / Serum Institute of India IPV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01831050 | May 2013 → Apr 2014 | poliomyelitis | Fidec Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Serum Institute of India IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01831050 ↗ |
| Modality | Vaccine | “Inactivated poliovirus vaccine produced by Nederland's Vaccin Instituut in Bilthoven, The Netherlands (acquired recently by Serum Institute of India [SII])” NCT01831050 ↗ |